Real world. Real answers. REAL-PE.
The largest real-world and near real-time dataset evaluating the EKOS system vs. Inari Medical’s™ FlowTriever™ system in PE interventions.
Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
The largest real-world and near real-time dataset evaluating the EKOS system vs. Inari Medical’s™ FlowTriever™ system in PE interventions.
No pulmonary embolism interventional therapy has been studied as much as EKOS. EKOS is the only interventional device to treat PE that provides efficacy and safety data with long-term outcomes. The evidence is in the data—and in the over 100,000 patients who have benefitted from the procedure.
15
Clinical trials
1200
Patients studied
100K+
Patients treated
You can have both with EKOS. See highlights and detailed data points behind some of the most critical studies in PE interventional treatment.
With the goal of gaining a deeper understanding of intervention for treating PE, Boston Scientific continues to invest in clinical studies.
HI-PEITHO represents the first-ever large-scale transatlantic, multi-center, prospective, randomized, controlled trial for an interventional device in pulmonary embolism (PE). It has been designed to address critical gaps in clinical evidence by comparing the clinical benefit of intervention with EKOS vs anticoagulation alone.